University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 12 of 24
Virtual Reality Device for Rehabilitation of Stroke Patients
NCT04139980
Circadian Mechanisms Underlying Non-Dipping Blood Pressure in Blacks
NCT03934255
Factors That Impact the Relationship Between Pulmonary Status and Susceptibility to Electronic Cigarette Use
NCT04151784
A Multidomain Approach to Preventing Dementia in African Americans: Cognitive Prescriptions
NCT03864536
The Impact of Insomnia on Pain in HIV
NCT04298658
Efficacy of BIPAMS for Restless Legs Syndrome in Adults With Multiple Sclerosis: A Pilot Study
NCT04061681
Effect of Low Carbohydrate Versus Low Fat Diet in the Treatment of Dyslipidemia in Obese Children With Metabolic Syndrome
NCT03937960
Liposomal Bupivacaine in Rotator Cuff Repair
NCT03738696
Healthy Homes, Healthy Habits
NCT03433456
Comparison of Standard of Care Guidelines for Mycoplasma Genitalium Infections Among Men With Non-gonococcal Urethritis
NCT03910907
Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV)
NCT04080245
Pilot Optimization Trial of Decision Partnering Intervention for Advanced Cancer Family Caregivers
NCT03947606
Low Vision Occupational Therapy in Parkinson's Disease
NCT04127838
Abemaciclib and Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer
NCT03938337
To Compare Different Soft Tissue Grafts at the Time of Lateral Ridge Augmentation Procedure.
NCT03774888
Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss
NCT03850990
Lidocaine Infusion or Quadratus Lumborum Block and Intrathecal Morphine, Versus Intrathecal Morphine Alone
NCT03658109
Incentive Spirometry Prehabilitation Study
NCT03994848
Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes
NCT03758742
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
NCT03781817
Using Bluetooth Beacon Technology to Reduce Distracted Pedestrian Behavior
NCT03604497
Optimizing Anesthesia for Post Partum Tubal Ligations
NCT03993314
Movement-2-Music: Lakeshore Examination of Activity, Disability, and Exercise Response Study
NCT03797378
Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy
NCT03996603
BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment
NCT03860311
Evaluating Novel Approaches for Estimating Awake and Sleep Blood Pressure
NCT04307004
An Artificial Intelligence Assisted Telehealth Intervention to Promote Self-Management in Patients With Type 2 Diabetes Mellitus (Qualitative Interview)
NCT03868813
Comparing High and Normal Protein Diets for the Dietary Remission of Type 2 Diabetes
NCT03832933
Effect of Phosphorus Additives on the Metabolome in Healthy Adults
NCT03841786
Postoperative Aspirin and Ankle Fracture Healing
NCT03765619
Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices
NCT03910413
Non-Encapsulated Heme Levels in Adult Cardiac Surgery
NCT04043507
Direct Application of Systane Complete to Contact Lenses
NCT03848221
Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis
NCT03923049
Regional Anesthesia to Reduce Opioid Use Following Functional Endoscopic Sinus Surgery
NCT03757715
Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection
NCT03762473
Chronic Low Back Pain Graded - Exposure Psychoeducation Intervention
NCT03909048
Fluoroscopic-Guided Micropuncture Technique for Common Femoral Artery Access
NCT03955653
Postpartum HPV Vaccination
NCT03451071
To Compare Two Commonly Used Soft Tissue Grafting Techniques to Achieve Coronal Flap Advancement and Root Coverage
NCT03566108
South-seq: Deoxyribonucleic Acid (DNA) Sequencing for Newborn Nurseries in the South
NCT03842995
Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency
NCT03679598
Improving Thinking in Everyday Life: Pilot Study A
NCT03873844
Motivational Encouragement With Networks (MEN) for Healthy Eating Activity Resting Together (HEART) Health Study
NCT03693768
The Diurnal Rhythm in Natriuretic Peptide Levels
NCT03834168
Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
NCT03859024
Comparing NicoBloc to Nicotine Lozenges
NCT03720899
Obesity Risk in African American Women is Determined by a Diet-by-phenotype Interaction
NCT03499509
Physical Therapy After Reverse Total Shoulder Arthroplasty
NCT03547726
Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS
NCT03808545
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.